| Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium TGM Van Erp, E Walton, DP Hibar, L Schmaal, W Jiang, DC Glahn, ... Biological psychiatry 84 (9), 644-654, 2018 | 824 | 2018 |
| High-potency cannabis and the risk of psychosis M Di Forti, C Morgan, P Dazzan, C Pariante, V Mondelli, TR Marques, ... The British Journal of Psychiatry 195 (6), 488-491, 2009 | 762 | 2009 |
| Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study JB Kirkbride, P Fearon, C Morgan, P Dazzan, K Morgan, J Tarrant, T Lloyd, ... Archives of general psychiatry 63 (3), 250-258, 2006 | 749 | 2006 |
| Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study P Fearon, JB Kirkbride, C Morgan, P Dazzan, K Morgan, T Lloyd, ... Psychological medicine 36 (11), 1541-1550, 2006 | 726 | 2006 |
| Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period I Jones, PS Chandra, P Dazzan, LM Howard The Lancet 384 (9956), 1789-1799, 2014 | 714 | 2014 |
| Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study M Di Forti, A Marconi, E Carra, S Fraietta, A Trotta, M Bonomo, F Bianconi, ... The Lancet Psychiatry 2 (3), 233-238, 2015 | 691 | 2015 |
| Altering the course of schizophrenia: progress and perspectives MJ Millan, A Andrieux, G Bartzokis, K Cadenhead, P Dazzan, P Fusar-Poli, ... Nature reviews Drug discovery 15 (7), 485-515, 2016 | 619 | 2016 |
| Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users M Di Forti, H Sallis, F Allegri, A Trotta, L Ferraro, SA Stilo, A Marconi, ... Schizophrenia bulletin 40 (6), 1509-1517, 2014 | 599 | 2014 |
| Reliability and comparability of psychosis patients’ retrospective reports of childhood abuse HL Fisher, TK Craig, P Fearon, K Morgan, P Dazzan, J Lappin, ... Schizophrenia bulletin 37 (3), 546-553, 2011 | 523 | 2011 |
| The dietary pattern of patients with schizophrenia: a systematic review S Dipasquale, CM Pariante, P Dazzan, E Aguglia, P McGuire, V Mondelli Journal of psychiatric research 47 (2), 197-207, 2013 | 502 | 2013 |
| Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings S Navari, P Dazzan Psychological medicine 39 (11), 1763-1777, 2009 | 403 | 2009 |
| Regional gray matter volume abnormalities in the at risk mental state SJ Borgwardt, A Riecher-Rössler, P Dazzan, X Chitnis, J Aston, M Drewe, ... Biological psychiatry 61 (10), 1148-1156, 2007 | 379 | 2007 |
| Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment V Mondelli, P Dazzan, N Hepgul, M Di Forti, M Aas, A D'Albenzio, ... Schizophrenia research 116 (2-3), 234-242, 2010 | 365 | 2010 |
| Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume V Mondelli, A Cattaneo, MB Murri, M Di Forti, R Handley, N Hepgul, ... The Journal of clinical psychiatry 72 (12), 20080, 2011 | 353 | 2011 |
| Parental separation, loss and psychosis in different ethnic groups: a case-control study C Morgan, J Kirkbride, J Leff, TOM Craig, G Hutchinson, K McKenzie, ... Psychological medicine 37 (4), 495-503, 2007 | 344 | 2007 |
| Stress sensitivity, aberrant salience, and threat anticipation in early psychosis: an experience sampling study U Reininghaus, MJ Kempton, L Valmaggia, TKJ Craig, P Garety, ... Schizophrenia bulletin 42 (3), 712-722, 2016 | 333 | 2016 |
| Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study P Dazzan, KD Morgan, K Orr, G Hutchinson, X Chitnis, J Suckling, ... Neuropsychopharmacology 30 (4), 765-774, 2005 | 318 | 2005 |
| Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ... Psychological medicine 46 (15), 3231-3240, 2016 | 315 | 2016 |
| Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis V Mondelli, S Ciufolini, M Belvederi Murri, S Bonaccorso, M Di Forti, ... Schizophrenia bulletin 41 (5), 1162-1170, 2015 | 311 | 2015 |
| Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users M Di Forti, C Iyegbe, H Sallis, A Kolliakou, MA Falcone, A Paparelli, ... Biological psychiatry 72 (10), 811-816, 2012 | 308 | 2012 |
Robin M Murrayinstitute of psychiatry, psychology, and neuroscienceยืนยันอีเมลแล้วที่ kcl.ac.uk
